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Introduction: We  assessed if patients with known hypoglycaemia present on other occa-
sions  with non-specific symptoms associated with (but not diagnosed as) hypoglycaemia,
potentially representing missed hypoglycaemia.
Methods: 335 primary care records (5/2/12-4/2/13) from patients aged >65 (79 on insulin, 85
on  sulphonylureas, 121 on metformin only, 50 without diabetes) were assessed for hypogly-
caemia episodes and consultations with non-specific symptoms, “hypo clues”.
Results: 27/79(34%) insulin-treated patients had >1 documented hypoglycaemia episode,
compared to 4/85(5%) sulphonylurea-treated patients, 2/121(2%) metformin-only treated
patients, and none without diabetes, p < 0.001.
“Hypo clue” consultations were common: 1.37 consultations/patient/year in insulin-
treated patients, 0.98/patient/year in sulphonylurea-treated, 0.97/patient/year in metformin
only-treated, and 0.78/patient/year in non-diabetic patients, p = 0.34. In insulin-treated
patients with documented hypoglycaemia, 20/27(74%) attended on another occasion withPlease cite this article in press as: S.V. Hope, et al., Are we missing hypoglycaemia? Elderly patients with insulin-treated dia-
betes present to primary care frequently with non-specific symptoms associated with hypoglycaemia, Prim. Care Diab. (2017),
http://dx.doi.org/10.1016/j.pcd.2017.08.004
a  “hypo clue” symptom, compared to 21/52(40%) of those without hypoglycaemia, p = 0.008.
No  significant difference in the other treatment groups.
Nausea, falls and unsteadiness were the most discriminatory symptoms: 7/33(21%) with
hypoglycaemia attended on another occasion with nausea compared to 14/302(5%) without
hypoglycaemia, p = 0.002; 10/33(30%) vs 36/302(12%) with falls, p = 0.007; and 5/33(15%) vs
13/302(4%) with unsteadiness, p = 0.023.
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Conclusions: Non-specific symptoms are common in those >65 years. In insulin-treated
patients at high hypoglycaemia risk, nausea, falls and unsteadiness should prompt con-
sideration of hypoglycaemia.
© 2017 The Authors. Published by Elsevier Ltd on behalf of Primary Care Diabetes Europe.
This is an open access article under the CC BY license (http://creativecommons.org/1.  Introduction
Tight glycaemic control in order to prevent long-term compli-
cations of diabetes [1,2] has been associated with an increased
prevalence of hypoglycaemia in Type 1 [3] and Type 2 dia-
betes [4]. Increasing prevalence of diabetes coupled with
longer life expectancy, and thus longer diabetes duration,
means there is an increasing elderly population on poten-
tially hypoglycaemia-causing medications such as insulin and
sulphonylureas [5–7].
Hypoglycaemia has numerous direct risks such as falls,
accidents, hospitalisation, impact on driving, fear and adverse
effects on quality of life, arrhythmias, and long-term cogni-
tion [8]. It also brings the risk of becoming less aware of the
symptoms – hypoglycaemia unawareness – which leads into
a vicious circle [9].
The recognition that elderly people on hypoglycaemia-
causing medications may be particularly vulnerable has led to
alterations of guidelines, incorporating more  relaxed HbA1c
targets for frail elderly, or those with multiple comorbidities
[10–12].
Hypoglycaemia symptoms in elderly people are less pro-
nounced than in younger patients [13–15]. Hypoglycaemia
is under-reported, and under-recognised – by patients, car-
ers and healthcare professionals [16–18]. Symptoms also vary
much more  between episodes in the same person than is
often appreciated [19]. These factors complicate estimates of
the prevalence of hypoglycaemia, almost certainly leading to
under-estimation.
As blood sugar levels fall, the autonomic symptoms of
sweating, palpitations, and anxiety first occur; these stim-
ulate food intake, in order to restore blood glucose levels
[20]. However autonomic symptoms become less prominent
in older age [13,21], and glucose levels may thus fall into
the “neuroglycopenic” range before self-correction. Symptoms
of insufficient cerebral glucose are non-specific, includ-
ing unsteadiness, light-headedness, tiredness and confusion
[8,22] – symptoms seen commonly in the general population
[23–25], and particularly in elderly patients for many  other
reasons too [26,27].
The symptoms most associated with hypoglycaemia have
been reported [9,20,28,29], including those particularly seen
in the elderly [14]. However, their non-specific nature, along
with multiple alternative explanations, including possible co-
morbidities, mean that hypoglycaemia may not be recognised.
This study aimed to establish if patients at risk of hypo-
glycaemia present more  to primary care with non-specificPlease cite this article in press as: S.V. Hope, et al., Are we mis
betes present to primary care frequently with non-specific sympt
http://dx.doi.org/10.1016/j.pcd.2017.08.004
symptoms which may represent unrecognised episodes of
hypoglycaemia.licenses/by/4.0/).
2.  Method
We performed a cross-sectional survey in one primary care
practice (list size: ∼11,000, ∼3300 > 65 years old) based in a
small market town and with a large rural patient popula-
tion. The practice’s Egton Medical Information Systems (EMIS)
database was used to identify all patients aged 65 or over
who were treated with insulin (n = 79), sulphonylureas (but
not insulin) (n = 85), or metformin only (n = 121), and 50 age-
matched non-diabetic patients.
One author (SH: a geriatrician) systematically reviewed
patients’ consultation notes over a one year period (5/2/12-
4/2/13), to identify any episodes of hypoglycaemia (defined
below), or any “hypo clue consultations” – consultations
with non-specific symptoms known to be associated with
hypoglycaemia (see below), where no other obvious expla-
nation or subsequent diagnosis was recorded. The records
were reviewed sequentially using the practice’s internal com-
puter number for each patient (essentially a random number).
Review of the consultation records was performed indepen-
dently of patient characteristics which were collected on a
separate occasion: age, diabetes details, treatment, and gly-
cated haemoglobin (HbA1c) blood test results.
2.1.  Definition  of  hypoglycaemia
Hypoglycaemia episodes were defined as episodes having
been directly confirmed by a doctor or nurse, paramedic or
hospital (although the blood glucose was not always recorded).
2.2.  Definition  of  “hypo  clue”  consultations
A “hypo clue consultation” was defined as one or more  of
the following symptoms recorded in the primary care records,
without an obvious explanation or subsequent diagnosis doc-
umented – or documentation that hypoglycaemia had been
considered. The symptoms (or synonyms) included were
based on the work by Jaap et al. [14]: shivering, shaking, sweat-
ing, pounding heart/palpitations, lip tingling, dry mouth,
apprehension, anxiety, agitation, confusion, odd behaviour,
lethargy/fatigue, tiredness, drowsiness, weakness, speech
difficulty, light-headedness, dizziness, unsteadiness, incoor-sing hypoglycaemia? Elderly patients with insulin-treated dia-
oms associated with hypoglycaemia, Prim. Care Diab. (2017),
dination, feeling unwell, nausea, hunger, headache, double or
blurred vision, depression symptoms, difficulty concentrating,
and memory  complaints [14]. Unexplained waking and falls
were also included due to clinical experience.
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Fig. 1 – Frequency of documented hypoglycaemia and “hypo clue” consultations (per person per year) according to
treatment group, in patients >65 years. p < 0.001 for a difference in rates of hypoglycaemia across the groups; p = 0.34 for a
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.3.  Analysis
he majority of the data was non-parametric; thus
edian results and interquartile ranges are presented,
nd chi2/Fisher’s exact tests used for comparing frequencies
cross groups and for the binary analyses of “at least one”
ypoglycaemia episode or “hypo clue” consultation over the
ear by treatment group.
Frequency of presentation with individual “hypo clue”
ymptoms was assessed. Individual symptom frequencies
ere compared in patients who had, and those who had not
ad, a recognised episode of hypoglycaemia on another occa-
ion, using chi2/Fisher’s exact tests.
The median HbA1c of those with/without at least one hypo-
lycaemia or “hypo clue” consultation per treatment group
as compared using the Mann Whitney test.
.4.  Ethics
he research project was based on an initial audit within the
ractice, which did not require ethical permission.
.  Results
.1.  Frequency  of  hypoglycaemia
t least one episode of hypoglycaemia was recorded for
7/79 (34%) insulin-treated patients, compared to 4/85 (5%)
ulphonylurea-treated patients, 2/121 (2%) metformin-only
reated patients, and none in patients without diabetes.Please cite this article in press as: S.V. Hope, et al., Are we mis
betes present to primary care frequently with non-specific sympt
http://dx.doi.org/10.1016/j.pcd.2017.08.004
he total frequency was significantly higher in insulin-
reated patients: 51 episodes (0.65 episodes/patient/year),
ompared to 5 episodes in the 85 patients with sulpho-
ylureas (0.06 episodes/patient/year), and 3 in the 121(0.02 episodes/patient/year) for the metformin-only treated
patients, p < 0.001, Fig. 1.
3.2.  Frequency  of  “hypo  clue”  consultations
Even patients without diabetes had frequent consultations
with at least one non-specific symptom without other obvious
documented explanation (feasibly due to hypoglycaemia in an
at-risk patient), 0.78 consultations/patient/year (39 consulta-
tions in 50 patients). Rates of “hypo clue” consultations were
similar for all patients with diabetes, regardless of treatment
(insulin 1.37, sulphonylureas 0.98, metformin 0.97 consulta-
tions/patient/year; p = 0.34), Fig. 1.
3.3.  Reported  symptoms  in  “hypo  clue”  consultations
The most commonly reported non-specific symptoms over-
all in this study, in decreasing order of frequency, were
lethargy/tiredness (47/335, 14%), falls (46/335, 13.7%), feel-
ing unwell (37/335, 11%), dizziness/light-headedness (35/335,
10.5%), depression symptoms (28/335, 8.4%), nausea (21/335,
6.3%), and unsteadiness (18/335, 5.4%).
3.4.  Consultation  with  possible  “hypo  clue”  symptoms
in those  with/without  documented  hypoglycaemia
In those patients who were insulin-treated and had at least
one documented episode of documented hypoglycaemia over
the year, 20/27 (74%) had presented on at least one other
occasion with a “hypo clue” symptom, Fig. 2. This was in
comparison to 21/52 (40%) of those insulin-treated patientssing hypoglycaemia? Elderly patients with insulin-treated dia-
oms associated with hypoglycaemia, Prim. Care Diab. (2017),
without a documented hypoglycaemia episode, p = 0.008. In
sulphonylurea and metformin treated patients with at least
one document episode of hypoglycaemia over the year, 2/4
(50%) and 1/2 (50%) respectively had also presented at least
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Fig. 2 – Proportion of patients who  had at least one documented “hypo clue” consultation over the year, and whether they
the yhad also had a documented episode of hypoglycaemia over 
once with possible “hypo clue” symptoms, with no difference
in rates between those with or without documented hypo-
glycaemia, p = 1.0. The odds ratio for insulin-treated patients
having a hypoglycaemia episode if they had consulted on
another occasion with a possible “hypo clue” symptom, was
4.2, compared to 1.1 in sulphonylurea or metformin only-
treated patients.
3.5.  Symptoms  in  “hypo  clue”  consultations  in  those
with/without  documented  hypoglycaemia
When the rates were compared overall in those with/without
at least one episode of documented hypoglycaemia, the symp-
toms that were significantly more  common were nausea (7/33,
21.2% vs 14/302, 4.6%, p = 0.002), falls (10/33, 33.3% vs 36/302,
11.9%, p = 0.007), unsteadiness (5/33, 15.2% vs 13/302, 4.3%,
p = 0.02), and depression symptoms (6/33, 18.2% vs 22/302,
7.3%, p = 0.044).
The majority of patients (27/33, 81.8%) with at least one
documented episode of hypoglycaemia were insulin-treated.
Of these, 9/27 (33.3%) had presented on another occasion with
a fall, compared to 4/52 (7.7%) insulin-treated patients with-
out a documented episode of hypoglycaemia, p = 0.008; and
a higher proportion had presented with unsteadiness (5/27,
18.5% vs 2/52, 3.9%), p = 0.043. Presentation with nausea was
also more  frequent in those insulin-treated patients with a
recognised/reported episode of hypoglycaemia over the year:
6/27 (22.2%) vs 1/52 (1.9%), p = 0.006.
3.6.  Relationship  with  HbA1cPlease cite this article in press as: S.V. Hope, et al., Are we mis
betes present to primary care frequently with non-specific sympt
http://dx.doi.org/10.1016/j.pcd.2017.08.004
Hypoglycaemia was unrelated to HbA1c (p > 0.4), Fig. 3. There
was also no relationship with “hypo clue” consultations and
HbA1c, p > 0.3 for all.ear.
4.  Discussion
Non-specific symptoms are a common presentation to pri-
mary care in patients over 65 with and without diabetes.
However we  have shown that patients at high risk of
hypoglycaemia – patients over the age of 65 who  are insulin-
treated and have had a recognised episode of hypoglycaemia,
present to primary care on other occasions with unexplained
non-specific symptoms which may represent unrecognised
hypoglycaemia. Falls, unsteadiness and nausea are particu-
larly worth noting.
4.1.  Strengths  and  limitations
This study examined the difficult question of whether addi-
tional episodes of hypoglycaemia might be being missed in the
older population. Primary care consultation records from just
one primary care practice were used, albeit a reasonably large
one. This meant reliance on documentation (coding and free
text) by a limited number of staff; however this may also have
offered more  internal consistency for recording and compar-
ing the vague symptoms between patients in this population.
The similar rates of “hypo clue” consultations seen in sulpho-
nylurea, metformin and non-diabetic patients is reasonably
reassuring for consistency of the approach for identification
of these consultations.
The “hypo clue” consultation definition used was deliber-
ately all-embracing – hence high rates were seen in patients
without diabetes. Even so, more  “hypo clue” consultations
were seen in insulin-treated patients who had also had a docu-
mented episode of hypoglycaemia. This rate may be artificiallysing hypoglycaemia? Elderly patients with insulin-treated dia-
oms associated with hypoglycaemia, Prim. Care Diab. (2017),
elevated as this group of patients could consult more  often. We
tried to address this by presenting the results comparing those
with and without episodes of hypoglycaemia within treatment
groups.
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The definition of hypoglycaemia, in contrast, was taken as
 strict definition, i.e. only those episodes documented as hav-
ng been confirmed in some way by a healthcare professional.
his will under-estimate the frequency of hypoglycaemia,
nd may preferentially identify more  “severe” episodes. This
pproach combined with the small study size may have lim-
ted the chance of identifying possible associations with those
atients experiencing hypoglycaemia. In order to corroborate
ny relationships seen, a prospective study of possible “hypo
lue” symptoms and hypoglycaemia could be undertaken.
Although not captured in the current analysis, less “severe”
pisodes of hypoglycaemia (e.g. those which were self-treated
nd not reported to primary care) are obviously also important:
hey may potentially pose a risk for development of reduced
ypoglycaemia awareness and a subsequent more  “severe”
vent, in addition to as yet under-appreciated possible effects
.g. on long-term cognition. A study which also directly asked
atients about their experience/frequency of hypoglycaemia
ay prove valuable, perhaps combined with a more  intense
ut objective assessment of hypoglycaemia, e.g. using contin-
ous glucose monitoring.
Further study in a bigger dataset could be revealing: e.g. an
index” event of hypoglycaemia taken and preceding consul-
ations analysed to see if “hypo clue” consultations preceded
 recognised event – and thus potentially expose more  robust
red flag” symptoms – or corroborate those suggested in
he current study. A larger study would also allow more
ophisticated analyses to be done, in particular corrections
or factors which may have an impact on risk, such as age
30,31], comorbidities [31,32], and renal function [30]. In addi-Please cite this article in press as: S.V. Hope, et al., Are we mis
betes present to primary care frequently with non-specific sympt
http://dx.doi.org/10.1016/j.pcd.2017.08.004
ion, insulin-treated patients in the current study comprise
 heterogeneous group – i.e. some with long-standing Type
 diabetes, and others with Type 2 diabetes and more  recentcumented episode of “definite” hypoglycaemia.
initiation of insulin treatment. Although these patients may
have different rates of presentation with hypoglycaemia or
“hypo clues”, the underlying type of diabetes in clinical care
is not always clearly defined or obvious [33], and thus an all-
encompassing “insulin-treated” group was felt to be a more
useful analysis in the current study.
Finally, HbA1c analysis was limited as it was based on a sin-
gle HbA1c level from the year; and therefore does not reflect
potential variation (and possible altered risks) over the year.
No apparent relationship with hypoglycaemia or “hypo clues”
was seen in the current study. This particular practice had
been subject to a similar audit previously, and thus it is pos-
sible that the frequency of patients with very low HbA1c was
lower than average.
4.2.  Comparison  with  previous  literature
Consistent with published literature, we  found that docu-
mented hypoglycaemia is more  frequent in insulin-treated
patients, and the finding that 34% of insulin-treated patients
had a “definite” episode of hypoglycaemia confirmed by a
healthcare professional over the year is consistent with the
7–46% in insulin-treated patients of different durations in
the UK Hypoglycaemia Study [6]: as previously mentioned,
the insulin-treated patients in the current study comprised
a heterogeneous group. 5% of sulphonylurea-treated patients
having an episode of hypoglycaemia is also consistent with
the 7% seen in the UK Hypoglycaemia Study [6].
18/50 (36%) of patients without diabetes had a “hypo clue”sing hypoglycaemia? Elderly patients with insulin-treated dia-
oms associated with hypoglycaemia, Prim. Care Diab. (2017),
consultation by our definition. As previously discussed, this
was an all-embracing definition, which included many  non-
specific symptoms frequently presenting to primary care.
Although not directly comparable, other primary care studies
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have found 22-48% patients presenting with symptoms which
could not be given a same-day diagnosis [23].
Regarding presentation with non-specific symptoms,
lethargy/fatigue, feeling “generally unwell”, falls, and light-
headedness/dizziness were the most frequently reported,
each in over 10% of these patients aged >65. However falls
and unsteadiness, along with nausea, were reported signifi-
cantly more  frequently in those who had also had (on another
occasion) a hypoglycaemia episode. Overall 21% of those with
at least one episode of documented hypoglycaemia over the
year had attended on another occasion with nausea without a
documented diagnosis, in comparison to 5% of those without
an episode of hypoglycaemia – and 22% vs 2% in those who
were insulin-treated.
It is perhaps not surprising falls were one of the most fre-
quently presenting symptoms, as they are one of the most
dramatic. However the difference of 30% vs 12% (or 33% vs 8%
of insulin-treated) patients presenting with a fall in those who
had/had not also had a documented hypoglycaemic episode
on a different occasion is marked. Kachroo et al. [34] identi-
fied in a study of over 21,000 patients with Type 2 diabetes,
those aged >75 who  had experienced a documented episode
of hypoglycaemia over a one-year period had an adjusted odds
ratio (aOR) for a fall-related event of 1.77 (95% CI 1.48–2.12), and
an increased risk was seen in patients with recurrent episodes
of hypoglycaemia.
Recognised symptoms associated with hypoglycaemia
which could predispose to falls include shakiness, anxiety,
confusion, lethargy/fatigue, tiredness, drowsiness, weakness,
light-headedness, dizziness, unsteadiness, incoordination,
and double or blurred vision [35]. The finding that unsteadi-
ness was the other most notable discriminatory symptom
may be consistent with this: 15% vs 4% (or 19% vs 4%
of insulin-treated) patients with/without hypoglycaemia on
another occasion presented with unsteadiness. When origi-
nally reviewing the symptoms associated with hypoglycaemia
in the elderly in comparison to younger adults, Jaap et al. iden-
tified that unsteadiness and light-headedness were amongst
the most frequently occurring and intense [14]. This study was
done by asking 102 insulin-treated patients with Type 2 dia-
betes who had experienced hypoglycaemia in the preceding
2 months their subjective experience of the presence of 22
symptoms of hypoglycaemia during a ‘typical’ hypoglycaemic
episode. Falls were not given as an option in this study, and
interestingly nausea had a low frequency (6%).
In contrast to the current study, a large meta-analysis
showed a 30% increase in severe hypoglycaemia with tight gly-
caemic control in people with Type 2 diabetes [4]. The apparent
lack of relationship in the current study may reflect the low
rates of “definite” hypoglycaemia documented, and at the
other end of the spectrum, the all-embracing definition for
“hypo clue” consultations used in this relatively small study
may have masked results.
4.3.  Clinical  implicationsPlease cite this article in press as: S.V. Hope, et al., Are we mis
betes present to primary care frequently with non-specific sympt
http://dx.doi.org/10.1016/j.pcd.2017.08.004
Patients >65 and who are insulin-treated are at the highest risk
of hypoglycaemia documented in primary care records, as will
be well-recognised by primary care practitioners. However,
hypoglycaemia in older adults is associated with non-specificx x x ( 2 0 1 7 ) xxx–xxx
and less intense symptoms than in younger people [13–15].
It is known to be under-reported to healthcare professionals
[18,36], which can be due to a failure to appreciate its signifi-
cance, or poor recognition [16,17] perhaps particularly in those
with Type 2 diabetes, who may not have had education to go
with the increased risk of hypoglycaemia with insulin [6], or
with increasing duration of diabetes [9]. Symptoms can dif-
fer between episodes in the same person, which can make
recognition especially challenging [19]. Additionally episodes
of hypoglycaemia can be poorly recalled by patients [37,38],
which may be exacerbated by cognitive impairment. There
may also be a fear of its implications such as relating to driving
[36]. However, as previously discussed, it carries a high mor-
bidity [8]. This means healthcare professionals need to take a
more  pro-active approach in enquiring about hypoglycaemia.
This study suggests those who have had a recognised
episode of hypoglycaemia seem more  likely to present on
another occasion with a non-specific symptom which could
conceivably be due to hypoglycaemia, and nausea, falls and
unsteadiness seem to be particularly notable. The likeli-
hood of this is corroborated by other published data, and as
such, insulin-treated patients presenting with these symp-
toms should be reviewed with hypoglycaemia in mind.
More recent guidelines for older adults [10–12] favour a
more  common-sense approach in actively addressing gly-
caemic targets, particularly in a more  elderly and frail
population, who can ill-afford to be exposed to risk fac-
tors for accidents [35,39,40] and cognitive decline [41–43].
As previously discussed the current study did not show a
clear relationship between hypoglycaemia or “hypo clue”
consultations and HbA1c, but much larger meta-analyses
have [44] – and additionally increased all-cause mortality has
been observed with HbA1c results below 7.5% [45]. On the
other hand, avoidance of hypoglycaemia is not as simple
as relaxing HbA1c targets – Munshi et al [46] demonstrated
using continuous glucose monitoring that 65% of a group
of (mainly insulin-treated) elderly patients with HbA1c >8%
experienced at least one episode of hypoglycaemia (blood glu-
cose <3.9 mmol/L) over 3 days’ monitoring.
At the very least however, clinicians should be alert to
the possibility of unrecognised hypoglycaemia in their older
insulin-treated patients, and review them with this in mind.
5.  Conclusion
Non-specific symptoms which can be symptoms of hypo-
glycaemia are common in a population over 65. However in
insulin-treated patients at risk of hypoglycaemia, these “hypo
clue” symptoms, in particular nausea, falls and unsteadiness,
may represent episodes of hypoglycaemia not recognised by
the patient. Thus GPs should consider a review, including of
diabetes medication, when patients report or present with
these symptoms.sing hypoglycaemia? Elderly patients with insulin-treated dia-
oms associated with hypoglycaemia, Prim. Care Diab. (2017),
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